Literature DB >> 21503961

SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.

Christophe Erneux1, William's Elong Edimo, Laurence Deneubourg, Isabelle Pirson.   

Abstract

The SH2 domain containing inositol 5-phosphatase 2 (SHIP2) belongs to the family of the mammalian inositol polyphosphate 5-phosphatases. The two closely related isoenzymes SHIP1 (or SHIP) and SHIP2 contain a N-terminal SH2 domain, a catalytic domain, potential PTB domain-binding sites (NPXY), and C-terminal proline-rich regions with consensus sites for SH3 domain interactions. In addition, SHIP2 contains a unique sterile alpha motif (SAM) domain that could be involved in SAM-SAM domain interactions with other proteins or receptors. SHIP2 also shows the presence of an ubiquitin interacting motif at the C-terminal end. SHIP2 is essentially a PI(3,4,5)P(3) 5-phosphatase that negatively controls PI(3,4,5)P(3) levels in intact cells and produce PI(3,4)P(2) . Depending on the cells and stimuli, PI(3,4)P(2) could accumulate at important levels and be a "second messenger" by its own. It could interact with a very large number of target proteins such as PKB or TAPP1 and 2 that control insulin sensitivity. In addition to its catalytic activity, SHIP2 is also a docking protein for a large number of proteins: Cytoskeletal, focal adhesion proteins, scaffold proteins, adaptors, protein phosphatases, and tyrosine kinase associated receptors. These interactions could play a role in the control of cell adhesion, migration, or endocytosis of some receptors. SHIP2 could be acting independently of its phosphatase activity being part of a protein network of some receptors, e.g., the EGF receptor or BCR/ABL. These non-catalytic properties associated to a PI phosphatase have also been reported for other enzymes of the metabolism of myo-inositol such as Ins(1,4,5)P(3) 3-kinases, inositol phosphate multikinase (IPMK), or PTEN.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503961     DOI: 10.1002/jcb.23146

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  24 in total

Review 1.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

2.  Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.

Authors:  Akiko Nagamachi; Akinori Kanai; Megumi Nakamura; Hiroshi Okuda; Akihiko Yokoyama; Satoru Shinriki; Hirotaka Matsui; Toshiya Inaba
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 3.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

Review 4.  INPPL1 gene mutations in opsismodysplasia.

Authors:  Anaïs Fradet; Jamie Fitzgerald
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

5.  Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia.

Authors:  Jennifer E Below; Dawn L Earl; Kathryn M Shively; Margaret J McMillin; Joshua D Smith; Emily H Turner; Mark J Stephan; Lihadh I Al-Gazali; Jozef L Hertecant; David Chitayat; Sheila Unger; Daniel H Cohn; Deborah Krakow; James M Swanson; Elaine M Faustman; Jay Shendure; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2012-12-27       Impact factor: 11.025

6.  Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.

Authors:  Cori Feist; Paul Holden; Jamie Fitzgerald
Journal:  Clin Dysmorphol       Date:  2016-10       Impact factor: 0.816

7.  A phosphatidylinositol lipids system, lamellipodin, and Ena/VASP regulate dynamic morphology of multipolar migrating cells in the developing cerebral cortex.

Authors:  Satoshi Yoshinaga; Takahiro Ohkubo; Shinji Sasaki; Mutsuo Nuriya; Yukino Ogawa; Masato Yasui; Hidenori Tabata; Kazunori Nakajima
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

Review 8.  Excitable networks controlling cell migration during development and disease.

Authors:  Xiaoguang Li; Yuchuan Miao; Dhiman Sankar Pal; Peter N Devreotes
Journal:  Semin Cell Dev Biol       Date:  2019-12-10       Impact factor: 7.727

Review 9.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

Review 10.  Endosomal transport via ubiquitination.

Authors:  Robert C Piper; Paul J Lehner
Journal:  Trends Cell Biol       Date:  2011-09-28       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.